Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:55 PM
Ignite Modification Date:
2025-12-24 @ 9:55 PM
NCT ID:
NCT05063032
Eligibility Criteria:
Inclusion criteria
* Left atrial flutter1 inducible during electrophysiological evaluation.
* Clinical indication for ablation: a) symptoms (palpitations, dizziness, syncope, breathlessness, derangement, heart failure), tachymiopathy, b) poor heart rate control, or c) recurrence after electrical cardioversion or failure of one antiarrhythmic drug.
* Informed consent.
1. Patients will be enrolled if LAFL is clinically suspected but finally randomized if this mechanism is established by electrophysiologic evaluation according to the criteria stated above.
Exclusion criteria
* Previous ablation of LAFL.
* Previous linear ablation in the LA except for pulmonary vein isolation.
* Absolute contraindication for oral anticoagulation.
* Stroke or acute coronary syndrome less than 3 months before ablation.
* Complex congenital heart disease.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05063032
Study Brief:
Protocol Section:
NCT05063032